.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Tru Infusion is stocked at 39 licensed dispensaries across Arizona, with the deepest coverage in Phoenix, Mesa, Chandler, El Mirage, and Flagstaff. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In August 2026, Tru Infusion’s mix concentrated into Edible at 44.59% share with 74.36% YoY growth and 15.39% MoM, while Flower contracted to 18.55% share with -56.62% YoY and -49.16% MoM. Vapor Pens slid to 13.43% share with -66.54% YoY and -19.78% MoM, and Concentrates held 17.45% share with -41.25% YoY and -16.57% MoM. Smaller formats retreated as Topical fell -27.83% YoY and -38.19% MoM at 3.97% share, and Tincture & Sublingual declined -17.22% YoY and -14.78% MoM at 2.00% share, while Capsules remained negligible at 0.02% share despite a 141.08% MoM uptick after a -76.77% YoY drop. The pattern implies a deliberate pivot toward value-priced Edible (average price $5.96) as the growth anchor while higher-ticket inhalables contract, concentrating demand but raising category-dependence risk.
The surge in Edible toward a 44.59% share alongside a -35.30% YoY drop in average price and a -31.59% YoY decline in total brand sales indicates price-led volume capture in one category rather than broad-based recovery, and the -66.54% YoY decline in Vapor Pens together with a -41.25% YoY in Concentrates signals erosion of the inhalable portfolio. With Edible ranked 10 in Arizona, the mix shift improves relevance in that aisle but leaves Tru Infusion exposed if Edible growth normalizes; the implication is to defend the Edible rank while selectively stabilizing Flower (currently -49.16% MoM) or low-share Tincture & Sublingual (-14.78% MoM) to diversify revenue without diluting the Edible-led momentum.
Competitive Landscape
Tru Infusion is ranked #10 in AZ Edible in August 2026, improving 6 positions from #16 in August 2025, and rising 8 spots from #18 just three months earlier; this coincides with reaching a new peak rank of #10 in August 2026 while the category leader Wyld held #1 but faced a 19.2% year-over-year sales decline, and OGEEZ stayed at #2 with a 2.8% increase, indicating Tru Infusion’s double-digit rank climb is occurring as the top tier fragments and opens space for upward mobility.
Notable Products
Indica Peach Gummies 10-Pack (100mg) posted the largest month-over-month surge at 59.7% and sits at rank 7, while Indica Watermelon Rosin Gummies 10-Pack (100mg) slid 6.5% at rank 6, indicating trading up toward fruit-forward non-rosin SKUs. Watermelon Strawberry Lime Gummy (100mg) rose 43.6% to rank 1 and Indica Blueberry Gummies 10-Pack (100mg) climbed 49.3% to rank 3, outpacing Sativa Strawberry Kiwi Gummies 10-Pack (100mg) at 17.1% and rank 9, a spread that tilts the mix toward Indica and hybrid fruit profiles. Eight of the top ten are Edible gummies with ranks concentrated from 1 through 9 and MoM gains ranging from 17.1% to 59.7%, with only one decline at -6.5% and a single non-gummy in rank 10, pointing to category consolidation around gummies. The product mix implies Tru Infusion is concentrating demand into a narrow set of high-velocity gummy SKUs, favoring Indica-led flavors and de-emphasizing rosin variants.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
